Works matching AU van der Zanden, Tjitske M.

Results: 9

A New Framework to Implement Model-Informed Dosing in Clinical Guidelines: Piperacillin and Amikacin as Proof of Concept.

Published in:

Frontiers in Pharmacology, 2020, v. 11, p. N.PAG, doi. 10.3389/fphar.2020.592204

By:

Hartman, Stan J. F.;
Swaving, Joost G. E.;
van Beek, Stijn W.;
van Groen, Bianca D.;
de Hoop, Marika;
van der Zanden, Tjitske M.;
ter Heine, Rob;
de Wildt, Saskia N.

Publication type:

Article

Development of Best Evidence Dosing Recommendations for Term and Preterm Neonates (NeoDose Project).

Published in:

Neonatology (16617800), 2023, v. 120, n. 2, p. 196, doi. 10.1159/000528012

By:

de Hoop-Sommen, Marika A.;
van der Zanden, Tjitske M.;
Allegaert, Karel;
Flint, Robert B.;
Simons, Sinno H.P.;
de Wildt, Saskia N.

Publication type:

Article

Rapid Implementation of Model-Based Dosing Recommendations During the Coronavirus Disease 2019 Pandemic.

Published in:

2021

By:

de Wildt, Saskia N.;
Verscheijden, Laurens F. M.;
van der Zanden, Tjitske M.

Publication type:

Letter

Neonatal Drug Formularies—A Global Scope.

Published in:

Children, 2023, v. 10, n. 5, p. 848, doi. 10.3390/children10050848

By:

Shaniv, Dotan;
Bolisetty, Srinivas;
Young, Thomas E.;
Mangum, Barry;
Ainsworth, Sean;
Elbers, Linda;
Schultz, Petra;
Cucchi, Melanie;
de Wildt, Saskia N.;
van der Zanden, Tjitske M.;
Caldwell, Neil;
Smits, Anne;
Allegaert, Karel

Publication type:

Article

Guiding future paediatric drug studies based on existing pharmacokinetic and efficacy data: Cardiovascular drugs as a proof of concept.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 9, p. 2888, doi. 10.1111/bcp.15781

By:

Smeets, Nori J. L.;
Raaijmakers, Lieke P. M.;
van der Zanden, Tjitske M.;
Male, Christoph;
de Wildt, Saskia N.

Publication type:

Article

Best Evidence-Based Dosing Recommendations for Dexmedetomidine for Premedication and Procedural Sedation in Pediatrics: Outcome of a Risk-Benefit Analysis By the Dutch Pediatric Formulary.

Published in:

Pediatric Drugs, 2022, v. 24, n. 3, p. 247, doi. 10.1007/s40272-022-00498-y

By:

Freriksen, Jolien J. M.;
van der Zanden, Tjitske M.;
Holsappel, Inge G. A.;
Molenbuur, Bouwe;
de Wildt, Saskia N.

Publication type:

Article

Does a Dose Calculator as an Add-On to a Web-Based Paediatric Formulary Reduce Calculation Errors in Paediatric Dosing? A Non-Randomized Controlled Study.

Published in:

Pediatric Drugs, 2020, v. 22, n. 2, p. 229, doi. 10.1007/s40272-020-00386-3

By:

van der Zanden, Tjitske M.;
de Hoog, Matthijs;
Windster, Jonathan D.;
van Rosmalen, Joost;
van der Sijs, I. Heleen;
de Wildt, Saskia N.

Publication type:

Article

Off‐Label, but on‐Evidence? A Review of the Level of Evidence for Pediatric Pharmacotherapy.

Published in:

Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 6, p. 1243, doi. 10.1002/cpt.2736

By:

van der Zanden, Tjitske M.;
Smeets, Nori J.L.;
de Hoop‐Sommen, Marika;
Schwerzel, Michiel F.T.;
Huang, Hui Jun;
Barten, Lieke J.C.;
van der Heijden, Joyce E.M.;
Freriksen, Jolien J.M.;
Horstink, Akira A.L.;
Holsappel, Inge H.G.;
Mooij, Miriam G.;
de Hoog, Matthijs;
de Wildt, Saskia N.

Publication type:

Article

Benefit‐Risk Assessment of Off‐Label Drug Use in Children: The Bravo Framework.

Published in:

Clinical Pharmacology & Therapeutics, 2021, v. 110, n. 4, p. 952, doi. 10.1002/cpt.2336

By:

van der Zanden, Tjitske M.;
Mooij, Miriam G.;
Vet, Nienke J.;
Neubert, Antje;
Rascher, Wolfgang;
Lagler, Florian B.;
Male, Christoph;
Grytli, Helene;
Halvorsen, Thomas;
de Hoog, Matthijs;
de Wildt, Saskia N.

Publication type:

Article